This document discusses nanopharmacology and its applications. It begins with a brief history of nanotechnology and defines nanopharmacology as applying nanomedicine and nanotechnology to living systems at the nanoscale. Various nanomaterials that can be used as drug carriers are described, including liposomes, polymers, dendrimers, metal oxides, quantum dots, fullerenes, and carbon nanotubes. The document outlines how nanotechnology can provide targeted drug delivery, reduce toxicity, and increase efficacy. Applications discussed include cancer treatment, heart disease, diabetes, skin creams, and COVID-19 diagnostic tests and vaccines. In conclusion, the document states that nanopharmacology will significantly change disease diagnosis, treatment and prevention